Stay updated on Comparing Uproleselan in AML Clinical Trial
Sign up to get notified when there's something new on the Comparing Uproleselan in AML Clinical Trial page.

Latest updates to the Comparing Uproleselan in AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAn entry 'Revision: v3.3.3' was added to the page's history, and the footer now removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page, reflecting a minor backend update with no changes to study data or navigation — to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedRecord History shows a new revision entry (v3.3.1) and removes the older entry (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedThe removal of the government funding/operating status notice is shown, while the rest of the study record content and version history remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check70 days agoChange DetectedThe latest screenshot shows the same page layout and header as the previous version, with only updates to the version history list and no substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check98 days agoChange DetectedUpgrade to v3.2.0 with added government-operating-status notice and expanded study-related sections; removing v3.1.0 confirms version update.SummaryDifference17%

Stay in the know with updates to Comparing Uproleselan in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Uproleselan in AML Clinical Trial page.